IGHM report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

GO_0045087Biological processinnate immune response
GO_0019731Biological processantibacterial humoral response
GO_0050829Biological processdefense response to Gram-negative bacterium
GO_0050853Biological processB cell receptor signaling pathway
GO_0002250Biological processadaptive immune response
GO_0006958Biological processcomplement activation, classical pathway
GO_0005615Cellular componentextracellular space
GO_0042571Cellular componentimmunoglobulin complex, circulating
GO_0005886Cellular componentplasma membrane
GO_0070062Cellular componentextracellular exosome
GO_0071756Cellular componentpentameric IgM immunoglobulin complex
GO_0071753Cellular componentIgM immunoglobulin complex
GO_0072562Cellular componentblood microparticle
GO_0009986Cellular componentcell surface
GO_0071757Cellular componenthexameric IgM immunoglobulin complex
GO_0042834Molecular functionpeptidoglycan binding
GO_0003697Molecular functionsingle-stranded DNA binding
GO_0034987Molecular functionimmunoglobulin receptor binding
GO_0031210Molecular functionphosphatidylcholine binding
GO_0003823Molecular functionantigen binding

IV. Literature review

[source]
Gene nameIGHM
Protein nameImmunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU)
Immunoglobulin mu-chain D-J4-region
Synonyms
DescriptionFUNCTION: Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens . The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen . .; FUNCTION: [Isoform 1]: Constant region of secreted IgM (sIgM), also known as the Fc region of IgM antibody. Able to multimerize, forms high order polymers, mainly pentamers and occasionally hexamers, providing for multivalency and high avidity recognition of antigens . Natural sIgM are polyreactive and recognize conserved self- and pathogen-derived structures, whereas immune sIgM are secreted only upon exposure to pathogens and are antigen-specific. Both natural and immune sIgM are required for an efficient humoral immune response to infection (By similarity). Mediates sIgM effector functions mostly via Fc receptors and the complement system. On lymphoid cells binds high-affinity Fc receptor FCMR and promotes induction of an efficient neutralizing IgG response while maintaining tolerance to self-antigens. Recruits C1q complement component to initiate the classical complement pathway, facilitating the recognition and neutralization of pathogens by the host. Together with C1q and mannose-binding lectin promotes the phagocytosis of apoptotic cells by macrophages, ensuring the clearance of potential autoimmune epitopes from tissues (By similarity). Involved in mucosal immunity. It is transported by transcytosis across mucosal epithelium by PIGR and secreted on the apical side in complex with PIGR secretory component to scan mucosal lining for pathogens. IgM-antigen complexes undergo FCMR-mediated retrotranscytosis across mucosal M cells toward antigen-presenting cells in mucosal lymphoid tissues (By similarity). .; FUNCTION: [Isoform 2]: Constant region of membrane-bound IgM, part of the B cell receptor complex (BCR). IgM BCR provides constitutive tonic signaling for B cell survival. Mediates pre-BCR signaling that regulates B cell selection and rearrangement of Ig genes via allelic exclusion. .

AccessionsA2N7P4
ENST00000637539.2 [P01871-2]
ENST00000390559.6 [P01871-1]
P01871
ENST00000626472.2 [P01871-1]